Macrophage recognition of periodate-treated erythrocytes: involvement of disulfide formation of the erythrocyte membrane proteins.
Upon exposure to 2 mM periodate at 0 degrees C for 15 min, mouse erythrocytes underwent membrane lipid oxidation, oxidation of cell surface sialyl residues into aldehyde-bearing derivatives, and oxidation of SH groups of the membrane proteins into disulfides. The periodate-treated erythrocytes exhibited a remarkable increase in rosette attachment to resident mouse peritoneal macrophages in the absence of serum. The relationship between the oxidation of the membrane constituents and the macrophage recognition of these cells was investigated. Periodate treatment of erythrocytes in the presence of butylated hydroxytoluene, an inhibitor of lipid oxidation, did not affect the subsequent attachment of the erythrocytes to the macrophages. Reduction of the periodate-treated erythrocytes with borohydride or cyanoborohydride did not affect the erythrocyte attachment. Neuraminidase treatment of erythrocytes before periodate did not affect the attachment either. On reduction of the disulfides of the membrane proteins with dithiothreitol, the periodate-treated erythrocytes lost their ability to attach to the macrophages. Erythrocytes treated with an SH-oxidizing agent, diamide, were then examined for the macrophage recognition. The diamide-treated cells also showed rosette attachment to the macrophages in the absence of serum, but did not when reduced with dithiothreitol. These results indicate that oxidation of the SH groups of the membrane proteins to disulfides causes reversible membrane changes that macrophages recognize, and it is this mechanism that is responsible for the macrophage recognition of the periodate-treated erythrocytes.
Beppu
M
M
Tokyo College of Pharmacy, Japan.
Ochiai
H
H
Kikugawa
K
K
D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D002448:Cell Adhesion; D003958:Diamide / Q000494:pharmacology; D004220:Disulfides; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000502:physiology*; D066298:In Vitro Techniques; D008264:Macrophages / Q000502:physiology*; D008563:Membrane Lipids / Q000097:blood; D008565:Membrane Proteins / Q000097:blood*; D051379:Mice; D010084:Oxidation-Reduction; D010504:Periodic Acid / Q000494:pharmacology*; D010587:Phagocytosis; D012794:Sialic Acids / Q000097:blood; D013439:Sulfhydryl Reagents / Q000494:pharmacology
D001095:Arachidonic Acids; D004220:Disulfides; D008563:Membrane Lipids; D008565:Membrane Proteins; D012794:Sialic Acids; D013439:Sulfhydryl Reagents; D010504:Periodic Acid; D003958:Diamide; D016718:Arachidonic Acid